Meningeal fibrosarcoma: a case report and review of the literature.
Meningeal Fibrosarcoma (MF) accounts only for 0.5% of the brain tumors. Since the clinical manifestations and radiologic findings are non-specific, the diagnosis can only be achieved by pathological examination of surgically removed specimens. MF are tumors that behave locally very aggressively and respond poorly to treatment, with reported median survivals ranging from 6 to 15 months. We report a new case of MF describing the peculiar onset as a slow growing mass in scalp with bone destruction and without neurological clinical findings.
Rovirosa
A
A
Radiotherapy and Oncology Department, Hospital Valle de Hebron, Autonoma University of Barcelona, Spain.
Vicente
P
P
Bellmut
J
J
Morales
S
S
Del Campo
J M
JM
Bodi
R
R
Ortega
A
A
D000328:Adult; D003131:Combined Modality Therapy; D005354:Fibrosarcoma / Q000000981:diagnostic imaging / Q000473:pathology* / Q000628:therapy; D006801:Humans; D008297:Male; D008577:Meningeal Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology* / Q000628:therapy; D011379:Prognosis; D012888:Skull Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology* / Q000628:therapy; D014057:Tomography, X-Ray Computed